Disc Medicine
IRON
132 hedge funds and large institutions have $1.35B invested in Disc Medicine in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 60 increasing their positions, 26 reducing their positions, and 12 closing their positions.
131% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 26
100% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 12
9% more funds holding
Funds holding: 121 → 132 (+11)
8% more capital invested
Capital invested by funds: $1.24B → $1.35B (+$105M)
0.81% less ownership
Funds ownership: 92.95% → 92.14% (-0.81%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
51% less call options, than puts
Call options by funds: $437K | Put options by funds: $884K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$19.4M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$14.3M |
| 3 |
State Street
Boston,
Massachusetts
|
+$11M |
| 4 |
AC
Armistice Capital
New York
|
+$7.51M |
| 5 |
Goldman Sachs
New York
|
+$5.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
-$56.7M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$11M |
| 3 |
PA
Perceptive Advisors
New York
|
-$7.81M |
| 4 |
FTM
First Turn Management
Del Mar,
California
|
-$6.26M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$4.32M |
IRON Hedge Fund Activity: Q3 2024 in Review
132 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q3 2024, worth a combined $1.35B — up 8.4% from $1.24B a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new IRON positions and 12 closed out — a net gain of 12 holders — while 60 added to existing stakes and 26 trimmed.
The largest buyer was BlackRock, adding an estimated $19.4M. The largest seller was Paradigm Biocapital Advisors, cutting an estimated $56.7M.
- 132 institutional investors held Disc Medicine (IRON) as of Q3 2024, up from 121 in Q2 2024.
- Funds reported $1.35B of Disc Medicine stock for Q3 2024, up 8.4% quarter-over-quarter.
- 24 funds opened new Disc Medicine positions in Q3 2024 and 12 closed out, a net change of +12 holders.
- The largest Disc Medicine buyer in Q3 2024 was BlackRock, an estimated $19.4M added.
- The largest Disc Medicine seller in Q3 2024 was Paradigm Biocapital Advisors, an estimated $56.7M sold.
Based on aggregated 13F filings for Q3 2024.